Each plan is customized so you get the best possible results for your bodys needs
While androgenetic alopecia (genetic hair loss) is often a common cause, lifestyle issues and nutritional deficiencies can sometimes be overlooked

Key selective action features: No Growth Hormone Receptor Binding: Does not activate GH receptors responsible for IGF-1 stimulation and systemic growth effects Preserved Glucose Metabolism: No impact on blood sugar regulation, insulin sensitivity, or diabetic risk markers No Tissue Growth Effects: Does not promote muscle hypertrophy, organ growth, or cell proliferation pathways Adipose-Specific Targeting: Works primarily through beta-3 adrenergic receptors concentrated in fat tissue No IGF-1 Elevation: Clinical trials confirmed no changes in serum IGF-1 levels at therapeutic doses Isolated Lipolytic Action: Maintains the fat-breaking properties of growth hormone fragment 176-191 without broader effects Selective Mechanism: Structural differences from full-length GH prevent binding to receptors mediating non-fat-related effects Clinical Validation: Human studies in 900+ participants confirmed selective fat metabolism without systemic hormonal changes The following guide provides detailed analysis of AOD-9604 s selective action and why this selectivity matters for safe, targeted fat metabolism

It is sold as a research reagent (research chemical, not for human use) by suppliers operating in the gray-market peptide space
That structure keeps checkout and policy information close to the purchase path while avoiding use instructions, outcome claims, or clinical framing
Combination GHRP-2 and HCG